Authors:
ZIETMAN AL
DALLOW KC
MCMANUS PA
HENEY NM
SHIPLEY WU
Citation: Al. Zietman et al., TIME TO 2ND PROSTATE-SPECIFIC ANTIGEN FAILURE IS A SURROGATE END-POINT FOR PROSTATE-CANCER DEATH IN A PROSPECTIVE TRIAL OF THERAPY FOR LOCALIZED DISEASE, Urology, 47(2), 1996, pp. 236-239
Citation: Ta. Diprete et Pa. Mcmanus, INSTITUTIONS, TECHNICAL CHANGE, AND DIVERGING LIFE CHANCES - EARNINGSMOBILITY IN THE UNITED-STATES AND GERMANY, American journal of sociology, 102(1), 1996, pp. 34-79
Authors:
KIKERI D
MARZEC U
NOE B
MACDONALD MJ
MCMANUS PA
LUMSDEN AB
NEYLAN JF
HARKER LA
Citation: D. Kikeri et al., IMPACT OF PLATELET ACTIVATION IN HEMODIALYSIS (HD) PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 494-494